Agonist-evoked calcium entry in vascular smooth muscle cells requires IP3 receptor-mediated activation of TRPC1

Eur J Pharmacol. 2008 Mar 31;583(1):135-47. doi: 10.1016/j.ejphar.2008.01.007. Epub 2008 Jan 26.

Abstract

Transient receptor potential canonical (TRPC) proteins have been proposed to function as plasma membrane Ca2+ channels activated by store depletion and/or by receptor stimulation. However, their role in the increase in cytosolic Ca2+ activated by contractile agonists in vascular smooth muscle is not yet elucidated. The present study was designed to investigate the functional and molecular properties of the Ca2+ entry pathway activated by endothelin-1 in primary cultured aortic smooth muscle cells. Measurement of the Ca2+ signal in fura-2-loaded cells allowed to characterize endothelin-1-evoked Ca2+ entry, which was resistant to dihydropyridine, and was blocked by 2-aminoethoxydiphenylborate (2-APB) and micromolar concentration of Gd3+. It was not activated by store depletion, but was inhibited by the endothelin ETA receptor antagonist BQ-123, and by heparin. On the opposite, thapsigargin-induced store depletion activated a Ca2+ entry pathway that was not affected by 2-APB, BQ-123 or heparin, and was less sensitive to Gd3+ than was endothelin-1-evoked Ca2+ entry. Investigation of the gene expression of TRPC isoforms by real-time RT-PCR revealed that TRPC1 was the most abundant. In cells transfected with TRPC1 small interfering RNA sequence, TRPC1 mRNA and protein expression were decreased by 72+/-3% and 86+/-2%, respectively, while TRPC6 expression was unaffected. In TRPC1 knockdown cells, both endothelin-1-evoked Ca2+ entry and store-operated Ca2+ entry evoked by thapsigargin were blunted. These results indicate that in aortic smooth muscle cells, TRPC1 is not only involved in Ca2+ entry activated by store depletion but also in receptor-operated Ca2+ entry, which requires inositol (1,4,5) triphosphate receptor activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticoagulants / administration & dosage
  • Anticoagulants / pharmacology
  • Calcium / metabolism*
  • Calcium Channel Agonists / pharmacology*
  • Calcium Signaling / drug effects
  • Cells, Cultured
  • Endothelin-1 / pharmacology
  • Fluorescent Antibody Technique
  • Gene Expression Regulation / drug effects
  • Heparin / administration & dosage
  • Heparin / pharmacology
  • Inositol 1,4,5-Trisphosphate Receptors / drug effects*
  • Male
  • Microinjections
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • RNA, Small Interfering
  • Rats
  • Rats, Wistar
  • Reverse Transcriptase Polymerase Chain Reaction
  • TRPC Cation Channels / agonists*
  • TRPC Cation Channels / genetics
  • Transfection
  • Vasoconstrictor Agents / pharmacology

Substances

  • Anticoagulants
  • Calcium Channel Agonists
  • Endothelin-1
  • Inositol 1,4,5-Trisphosphate Receptors
  • RNA, Messenger
  • RNA, Small Interfering
  • TRPC Cation Channels
  • Vasoconstrictor Agents
  • transient receptor potential cation channel, subfamily C, member 1
  • Heparin
  • Calcium